| 摘要 |
PURPOSE:To obtain a fibrinolytic agent containing a urokinase precursor as an active ingredient. CONSTITUTION:A fibrinolytic agent which contains a urokinase precursor as an active ingredient wherein the urokinase precursor in an amount [preferably 15,000-30,000 IU (urokinase conversion time/minute] enough to rapidly cause activation of the urokinase precursor at the initial period of administration (preferably within 7-15min after beginning of administration) is intravenously injected. The agent is preferably applied for treating thrombosis, especially myocardial infraction. The fibrinolytic agent shows two or more effects on reopening ratio of thrombosis in coronaria than a well-known fibrinolytic agent comprising UK precursor. The agent is intravenously administered, especially preferably by drip.
|
